The company is expecting 2025 EPS to range from $15.25 to $16.25, below the $16.33 FactSet consensus. Revenue is expected to decline by a mid-single-digit percent on a constant currency basis, as ...
Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...
Q2 2025 Results Conference Call February 10, 2025 5:00 PM ETCompany ParticipantsMatt Gunter - Investor RelationsTim Danker ...
No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...
A very brisk Boston and the rest of New England have seen temperatures slip 5 to 20 degrees below average since Monday just as folks on the Cape saw a little burst of snow yesterday. But after ...
They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...
In 2019, Stanford University professor Irv Weissman and a colleague published a paper that represented a new way to target some aggressive cancers.
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
Illinois legalized online sports betting in 2020 and dozens of online sportsbooks are now operating in the state. In this guide, we’ll cover everything you need to know about online sports ...
Prolium was set up by RTW in 2024. Last year also saw the New York-based investment fund involved in the launch of obesity biotech Kailera Therapeutics, which RTW said at the time was the fourth ...
But local biotech leaders see signs of change in 2025. Amid tough biotech industry market conditions last year, investors and Big Pharma companies were more likely to make deals with later-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback